Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...

Discover a review in which diabetes was investigated in 5 studies, with only one demonstrating a correlation between the condition and higher hospital readmission rates.